Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations

Fingolimod (FTY720), an immunotherapeutic drug targeting the sphingosine-1-phosphate receptor, is a widely used medication for relapsing-remitting multiple sclerosis (MS). Apart from the pivotal Phase III trials demonstrating efficacy against placebo and interferon-β-1a once weekly, sufficient clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Ayzenberg, Ilya, Hoepner, Robert, Kleiter, Ingo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767105/
https://www.ncbi.nlm.nih.gov/pubmed/26929636
http://dx.doi.org/10.2147/TCRM.S65558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767105/
https://www.ncbi.nlm.nih.gov/pubmed/26929636
http://dx.doi.org/10.2147/TCRM.S65558

Ejemplares similares